| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,702 |
18,845 |
$1.79M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,340 |
3,054 |
$368K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,884 |
5,348 |
$270K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,621 |
2,609 |
$246K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,309 |
2,308 |
$216K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,768 |
1,729 |
$155K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,229 |
1,229 |
$126K |
| 87070 |
|
16,159 |
13,517 |
$112K |
| 87184 |
|
14,651 |
12,309 |
$82K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,878 |
6,784 |
$64K |
| 99051 |
|
11,992 |
10,478 |
$62K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
18,457 |
15,096 |
$60K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,551 |
1,475 |
$47K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,499 |
1,658 |
$43K |
| 99050 |
|
5,211 |
4,697 |
$26K |
| 92551 |
|
2,264 |
2,257 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,499 |
4,392 |
$12K |
| 99188 |
|
1,045 |
1,045 |
$11K |
| D1206 |
Topical application of fluoride varnish |
375 |
375 |
$9K |
| 83655 |
|
443 |
439 |
$5K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
928 |
926 |
$5K |
| 96127 |
|
898 |
897 |
$4K |
| 92587 |
|
101 |
100 |
$3K |
| 99441 |
|
67 |
65 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
19 |
19 |
$2K |
| 92567 |
|
123 |
123 |
$1K |
| 99442 |
|
18 |
17 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
28 |
28 |
$1K |
| 96161 |
|
866 |
835 |
$783.03 |
| 90686 |
|
3,532 |
3,531 |
$542.47 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
64 |
62 |
$517.51 |
| 81002 |
|
167 |
152 |
$280.50 |
| 90619 |
|
59 |
59 |
$175.00 |
| 90716 |
|
235 |
235 |
$146.27 |
| 90707 |
|
246 |
246 |
$89.60 |
| 94664 |
|
19 |
19 |
$49.80 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
91 |
91 |
$41.64 |
| 99177 |
|
545 |
544 |
$9.11 |
| 36416 |
|
4,495 |
4,376 |
$6.87 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
64 |
62 |
$2.26 |
| 90633 |
|
292 |
292 |
$0.00 |
| 90648 |
|
575 |
575 |
$0.00 |
| 90734 |
|
74 |
74 |
$0.00 |
| 90670 |
|
1,146 |
1,145 |
$0.00 |
| 90685 |
|
267 |
266 |
$0.00 |
| 90715 |
|
41 |
41 |
$0.00 |
| 90680 |
|
681 |
679 |
$0.00 |
| 90744 |
|
163 |
163 |
$0.00 |
| 90698 |
|
368 |
368 |
$0.00 |
| 90723 |
|
469 |
469 |
$0.00 |
| 90677 |
|
275 |
275 |
$0.00 |
| 90696 |
|
12 |
12 |
$0.00 |
| 90656 |
|
14 |
14 |
$0.00 |
| 90688 |
|
14 |
14 |
$0.00 |